- Kairos Pharma named winner of 2026 Biotech Breakthrough Award for ENV-105
- Filing reiterates previously announced Phase 2 interim efficacy data in mCRPC
- No new clinical updates, financial guidance, or regulatory milestones reported
Signal #145603 · SEC 8-K
$KAPA SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $KAPA filing catalyst
Why did $KAPA trigger an AI stock catalyst alert?
$KAPA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Kairos Pharma receives Biotech Breakthrough Award for lead candidate ENV-105. Key points: - Kairos Pharma named winner of 2026 Biotech Breakthrough Award for ENV-105 - Filing reiterates previously announced Phase 2 interim efficacy data in mCRPC - No new clinical updates, financial guidance, or regulatory milestones reported
How did $KAPA stock react after the SEC filing?
After the SEC 8-K for $KAPA, observed market reaction: T0 price $0.49. Past moves do not guarantee future results.
Where can I get real-time $KAPA SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $KAPA via Telegram and the VIP Web Terminal from €10/month.